{
    "Trade/Device Name(s)": [
        "GLP systems Track"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K213486",
    "Predicate Device Reference 510(k) Number(s)": [
        "K093318"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JGS",
        "CEM",
        "CGZ",
        "JJE",
        "JQP"
    ],
    "Summary Letter Date": "October 25, 2021",
    "Summary Letter Received Date": "October 29, 2021",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.2160",
        "21 CFR 862.2100",
        "21 CFR 862.1665",
        "21 CFR 862.1600",
        "21 CFR 862.1170"
    ],
    "Regulation Name(s)": [
        "Sodium Test System",
        "Calculator/data processing module for clinical use",
        "Electrode, ion specific, sodium",
        "Electrode, ion specific, potassium",
        "Electrode, ion-specific, chloride"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Sodium",
        "Potassium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [
        "Primary tube",
        "Secondary aliquot tube"
    ],
    "Instrument(s)/Platform(s)": [
        "GLP systems Track",
        "Alinity c analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Photometric",
        "Potentiometric"
    ],
    "Methodologies": [
        "Laboratory automation",
        "Sample preparation",
        "Sample handling"
    ],
    "Submission Type(s)": [
        "Automated system",
        "Specimen collection device",
        "Sample preparation"
    ],
    "Document Summary": "FDA 510(k) summary for GLP systems Track, a modular laboratory automation system for clinical sample processing and integration with Alinity c analyzer.",
    "Indications for Use Summary": "GLP systems Track automates pre-analytical and post-analytical sample processing in clinical laboratories; Alinity c ICT measures sodium, potassium, and chloride in serum, plasma, or urine for diagnosis and monitoring of electrolyte and metabolic disorders.",
    "fda_folder": "Clinical Chemistry"
}